↓ Skip to main content

Dove Medical Press

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
34 Mendeley
Title
Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
Published in
Neuropsychiatric Disease and Treatment, August 2021
DOI 10.2147/ndt.s325000
Pubmed ID
Authors

Alina Wilkowska, Adam Włodarczyk, Maria Gałuszko-Węgielnik, Mariusz S Wiglusz, Wiesław J Cubała

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 12%
Student > Doctoral Student 4 12%
Student > Postgraduate 3 9%
Other 2 6%
Student > Bachelor 2 6%
Other 7 21%
Unknown 12 35%
Readers by discipline Count As %
Medicine and Dentistry 11 32%
Neuroscience 3 9%
Unspecified 2 6%
Psychology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 9%
Unknown 12 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2021.
All research outputs
#16,059,145
of 25,392,582 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,583
of 3,131 outputs
Outputs of similar age
#234,198
of 440,771 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#23
of 44 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,771 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.